Assessment of attenuation correction for myocardial PET imaging using combined PET/MRI.


Journal

Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology
ISSN: 1532-6551
Titre abrégé: J Nucl Cardiol
Pays: United States
ID NLM: 9423534

Informations de publication

Date de publication:
08 2019
Historique:
received: 19 05 2017
revised: 18 10 2017
pubmed: 24 11 2017
medline: 21 10 2020
entrez: 24 11 2017
Statut: ppublish

Résumé

To evaluate the frequency of artifacts in MR-based attenuation correction (AC) maps and their impact on the quantitative accuracy of PET-based flow and metabolism measurements in a cohort of consecutive heart failure patients undergoing combined PET/MR imaging. Myocardial viability studies were performed in 20 patients following a dual-tracer protocol involving the assessment of myocardial perfusion ( Average respiratory misalignment of (7 ± 4) mm of the PET-emission data and the AC maps was observed in 18 (90%) patients. Substantial changes in the lung volumes of the AC maps were observed in the test-retest analysis (ratio: 1.0 ± 0.2, range: 0.8-1.4). Susceptibility artifacts were observed in 10 (50%) patients, while six (30%) patients had TI artifacts. Average differences of 14 ± 10% were observed for PET images reconstructed with the artifactual AC maps. The combined artifact effects caused false-positive findings in three (15%) patients. Standard DIXON-AC maps must be examined carefully for artifacts and misalignment effects prior to AC correction of cardiac PET/MRI studies in order to avoid misinterpretation of biased perfusion and metabolism readings from the PET data.

Identifiants

pubmed: 29168158
doi: 10.1007/s12350-017-1118-2
pii: 10.1007/s12350-017-1118-2
pmc: PMC6660490
doi:

Substances chimiques

Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1107-1118

Commentaires et corrections

Type : CommentIn

Références

J Nucl Cardiol. 2002 Mar-Apr;9(2):240-5
pubmed: 11986572
J Nucl Med. 2004 Sep;45(9):1519-27
pubmed: 15347719
J Nucl Med. 2005 Sep;46(9):1481-7
pubmed: 16157531
J Nucl Med. 2006 Nov;47(11):1808-12
pubmed: 17079814
J Nucl Med. 2007 Feb;48(2):188-93
pubmed: 17268013
J Nucl Med. 2007 May;48(5):783-93
pubmed: 17475968
J Nucl Med. 2007 Jul;48(7):1112-21
pubmed: 17574974
Eur J Nucl Med Mol Imaging. 2008 Feb;35(2):305-10
pubmed: 17909791
J Nucl Med. 2009 Apr;50(4):520-6
pubmed: 19289430
Am J Cardiol. 1991 May 21;67(14):35D-43D
pubmed: 2035433
J Nucl Med. 2011 Dec;52(12):1914-22
pubmed: 22080447
J Am Coll Cardiol. 2012 May 8;59(19):1719-28
pubmed: 22554604
MAGMA. 2013 Feb;26(1):173-81
pubmed: 22996323
J Am Coll Cardiol. 1990 Apr;15(5):1032-42
pubmed: 2312957
Eur J Nucl Med Mol Imaging. 2013 Apr;40(4):594-601
pubmed: 23296642
J Nucl Med. 2013 Mar;54(3):402-15
pubmed: 23404088
Int J Cardiovasc Imaging. 2013 Aug;29(6):1351-60
pubmed: 23504215
J Nucl Med. 2013 Oct;54(10):1768-74
pubmed: 24009273
Med Image Comput Comput Assist Interv. 2013;16(Pt 3):17-24
pubmed: 24505739
J Nucl Med. 2014 Apr 24;55(Supplement 2):40S-46S
pubmed: 24762626
Eur J Radiol. 2014 Jul;83(7):1177-1183
pubmed: 24780817
Eur J Nucl Med. 1989;15(11):722-6
pubmed: 2583200
Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1574-80
pubmed: 26091704
J Med Imaging (Bellingham). 2015 Apr;2(2):024009
pubmed: 26158104
J Nucl Cardiol. 2017 Jun;24(3):839-846
pubmed: 26499770
EJNMMI Phys. 2014 Dec;1(1):101
pubmed: 26501459
MAGMA. 2016 Feb;29(1):75-87
pubmed: 26739263
Med Phys. 2016 Apr;43(4):1829
pubmed: 27036580
J Nucl Med. 2016 Oct;57(10):1654-1656
pubmed: 27561879
J Am Coll Cardiol. 2016 Oct 4;68(14):1590-8
pubmed: 27687201
J Nucl Med. 2017 May;58(5):840-845
pubmed: 28126884
J Nucl Med. 1994 Apr;35(4):693-8
pubmed: 8151396

Auteurs

Martin Lyngby Lassen (ML)

QIMP Group, Center for Medical Physics and Biomedical Engineering, General Hospital Vienna, Medical University of Vienna, 1090, Vienna, Austria. martin.lassen@meduniwien.ac.at.

Sazan Rasul (S)

Division of Nuclear Medicine, Department of Biomedical Engineering and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Dietrich Beitzke (D)

Division of Cardiovascular and Interventional Radiology, Department of Biomedical Engineering and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Marie-Elisabeth Stelzmüller (ME)

Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Jacobo Cal-Gonzalez (J)

QIMP Group, Center for Medical Physics and Biomedical Engineering, General Hospital Vienna, Medical University of Vienna, 1090, Vienna, Austria.

Marcus Hacker (M)

Division of Nuclear Medicine, Department of Biomedical Engineering and Image-guided Therapy, Medical University of Vienna, Vienna, Austria.

Thomas Beyer (T)

QIMP Group, Center for Medical Physics and Biomedical Engineering, General Hospital Vienna, Medical University of Vienna, 1090, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH